Lenalidomide enhances antigen-specific activity and decreases CD45RA expression of T cells from patients with multiple myeloma
The aim of this study was to investigate whether the specific T cell response against the multiple myeloma Ag HM1.24 is enhanced by the immunomodulatory drug lenalidomide (Revlimid). Ag-specific CD3+CD8+ T cells against the HM1.24 Ag were expanded in vitro by dendritic cells in 29 healthy donors and...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
July 6, 2011
|
| In: |
The journal of immunology
Year: 2011, Jahrgang: 187, Heft: 2, Pages: 1047-1056 |
| ISSN: | 1550-6606 |
| DOI: | 10.4049/jimmunol.1002460 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.4049/jimmunol.1002460 Verlag, lizenzpflichtig, Volltext: https://www.jimmunol.org/content/187/2/1047 
|
| Verfasserangaben: | Brigitte Neuber, Isabelle Herth, Claudia Tolliver, Stefan Schoenland, Ute Hegenbart, Dirk Hose, Mathias Witzens-Harig, Anthony D. Ho, Hartmut Goldschmidt, Bernard Klein and Michael Hundemer |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 181722123X | ||
| 003 | DE-627 | ||
| 005 | 20230710114158.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220921s2011 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4049/jimmunol.1002460 |2 doi | |
| 035 | |a (DE-627)181722123X | ||
| 035 | |a (DE-599)KXP181722123X | ||
| 035 | |a (OCoLC)1389786121 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Neuber, Brigitte |d 1974- |e VerfasserIn |0 (DE-588)1052913563 |0 (DE-627)789293188 |0 (DE-576)408653884 |4 aut | |
| 245 | 1 | 0 | |a Lenalidomide enhances antigen-specific activity and decreases CD45RA expression of T cells from patients with multiple myeloma |c Brigitte Neuber, Isabelle Herth, Claudia Tolliver, Stefan Schoenland, Ute Hegenbart, Dirk Hose, Mathias Witzens-Harig, Anthony D. Ho, Hartmut Goldschmidt, Bernard Klein and Michael Hundemer |
| 264 | 1 | |c July 6, 2011 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 21.09.2022 | ||
| 520 | |a The aim of this study was to investigate whether the specific T cell response against the multiple myeloma Ag HM1.24 is enhanced by the immunomodulatory drug lenalidomide (Revlimid). Ag-specific CD3+CD8+ T cells against the HM1.24 Ag were expanded in vitro by dendritic cells in 29 healthy donors and 26 patients with plasma cell dyscrasias. Ag-specific activation was analyzed by IFN-γ, granzyme B, and perforin secretion using ELISA, ELISPOT assay, and intracellular staining, and generation of Ag-specific T cells was analyzed by tetramer staining. Expression of T cell maturation markers (CD45RA, CD45R0, CCR7, and CD28) was investigated by flow cytometry. We found that activation of HM1.24-specific T cells from healthy donors and patients with plasma cell dyscrasias was enhanced significantly by lenalidomide and furthermore that the impact of lenalidomide on T cells depends on the duration of the exposure. Notably, lenalidomide supports the downregulation of CD45RA on T cells upon activation, observed in healthy donors and in patients in vitro and also in patients during lenalidomide therapy in vivo. We showed for the first time, to our knowledge, that lenalidomide enhances the Ag-specific activation of T cells and the subsequent downregulation of CD45RA expression of T cells in vitro and in vivo. | ||
| 700 | 1 | |a Krämer, Isabelle |d 1984- |e VerfasserIn |0 (DE-588)1025613481 |0 (DE-627)723627738 |0 (DE-576)370555724 |4 aut | |
| 700 | 1 | |a Tolliver, Claudia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schönland, Stefan |d 1969- |e VerfasserIn |0 (DE-588)122405226 |0 (DE-627)705896137 |0 (DE-576)293255792 |4 aut | |
| 700 | 1 | |a Hegenbart, Ute |e VerfasserIn |0 (DE-588)1028373708 |0 (DE-627)73062157X |0 (DE-576)35901903X |4 aut | |
| 700 | 1 | |a Hose, Dirk |d 1969- |e VerfasserIn |0 (DE-588)139824995 |0 (DE-627)613790308 |0 (DE-576)313431698 |4 aut | |
| 700 | 1 | |a Witzens-Harig, Mathias |e VerfasserIn |0 (DE-588)1050736516 |0 (DE-627)784812322 |0 (DE-576)404988970 |4 aut | |
| 700 | 1 | |a Ho, Anthony Dick |d 1948- |e VerfasserIn |0 (DE-588)108692477 |0 (DE-627)504904205 |0 (DE-576)19010466X |4 aut | |
| 700 | 1 | |a Goldschmidt, Hartmut |d 1956- |e VerfasserIn |0 (DE-588)102258023X |0 (DE-627)717003809 |0 (DE-576)365637386 |4 aut | |
| 700 | 1 | |a Klein, Bernard |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hundemer, Michael |d 1972- |e VerfasserIn |0 (DE-588)128390549 |0 (DE-627)372634001 |0 (DE-576)297117998 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The journal of immunology |d Rockville, Md. : American Association of Immunologists, 1916 |g 187(2011), 2, Seite 1047-1056 |h Online-Ressource |w (DE-627)269535217 |w (DE-600)1475085-5 |w (DE-576)079963838 |x 1550-6606 |7 nnas |a Lenalidomide enhances antigen-specific activity and decreases CD45RA expression of T cells from patients with multiple myeloma |
| 773 | 1 | 8 | |g volume:187 |g year:2011 |g number:2 |g pages:1047-1056 |g extent:10 |a Lenalidomide enhances antigen-specific activity and decreases CD45RA expression of T cells from patients with multiple myeloma |
| 856 | 4 | 0 | |u https://doi.org/10.4049/jimmunol.1002460 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.jimmunol.org/content/187/2/1047 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220921 | ||
| 993 | |a Article | ||
| 994 | |a 2011 | ||
| 998 | |g 128390549 |a Hundemer, Michael |m 128390549:Hundemer, Michael |d 910000 |d 910100 |e 910000PH128390549 |e 910100PH128390549 |k 0/910000/ |k 1/910000/910100/ |p 11 |y j | ||
| 998 | |g 102258023X |a Goldschmidt, Hartmut |m 102258023X:Goldschmidt, Hartmut |d 910000 |d 910100 |d 50000 |e 910000PG102258023X |e 910100PG102258023X |e 50000PG102258023X |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 9 | ||
| 998 | |g 108692477 |a Ho, Anthony Dick |m 108692477:Ho, Anthony Dick |d 910000 |d 910100 |e 910000PH108692477 |e 910100PH108692477 |k 0/910000/ |k 1/910000/910100/ |p 8 | ||
| 998 | |g 1050736516 |a Witzens-Harig, Mathias |m 1050736516:Witzens-Harig, Mathias |d 910000 |d 910100 |e 910000PW1050736516 |e 910100PW1050736516 |k 0/910000/ |k 1/910000/910100/ |p 7 | ||
| 998 | |g 139824995 |a Hose, Dirk |m 139824995:Hose, Dirk |d 910000 |d 910100 |e 910000PH139824995 |e 910100PH139824995 |k 0/910000/ |k 1/910000/910100/ |p 6 | ||
| 998 | |g 1028373708 |a Hegenbart, Ute |m 1028373708:Hegenbart, Ute |d 910000 |d 910100 |e 910000PH1028373708 |e 910100PH1028373708 |k 0/910000/ |k 1/910000/910100/ |p 5 | ||
| 998 | |g 122405226 |a Schönland, Stefan |m 122405226:Schönland, Stefan |d 910000 |d 910100 |e 910000PS122405226 |e 910100PS122405226 |k 0/910000/ |k 1/910000/910100/ |p 4 | ||
| 998 | |g 1025613481 |a Krämer, Isabelle |m 1025613481:Krämer, Isabelle |d 910000 |d 910100 |e 910000PK1025613481 |e 910100PK1025613481 |k 0/910000/ |k 1/910000/910100/ |p 2 | ||
| 998 | |g 1052913563 |a Neuber, Brigitte |m 1052913563:Neuber, Brigitte |d 910000 |d 910100 |e 910000PN1052913563 |e 910100PN1052913563 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN181722123X |e 4190530654 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 21.09.2022"],"id":{"eki":["181722123X"],"doi":["10.4049/jimmunol.1002460"]},"relHost":[{"part":{"extent":"10","volume":"187","year":"2011","pages":"1047-1056","text":"187(2011), 2, Seite 1047-1056","issue":"2"},"language":["eng"],"name":{"displayForm":["American Association of Immunologists"]},"origin":[{"publisher":"Oxford University Press ; Soc. ; American Association of Immunologists","dateIssuedDisp":"2025-","dateIssuedKey":"2025","publisherPlace":"Oxford ; Bethesda, Md. ; Rockville, Md."}],"corporate":[{"role":"isb","roleDisplay":"Herausgebendes Organ","display":"American Association of Immunologists"}],"pubHistory":["1.1916 -"],"title":[{"title":"The journal of immunology","title_sort":"journal of immunology"}],"id":{"issn":["1550-6606"],"zdb":["1475085-5"],"eki":["269535217"]},"note":["Gesehen am 18.08.2025"],"recId":"269535217","disp":"Lenalidomide enhances antigen-specific activity and decreases CD45RA expression of T cells from patients with multiple myelomaThe journal of immunology","type":{"media":"Online-Ressource","bibl":"periodical"},"physDesc":[{"extent":"Online-Ressource"}]}],"name":{"displayForm":["Brigitte Neuber, Isabelle Herth, Claudia Tolliver, Stefan Schoenland, Ute Hegenbart, Dirk Hose, Mathias Witzens-Harig, Anthony D. Ho, Hartmut Goldschmidt, Bernard Klein and Michael Hundemer"]},"language":["eng"],"recId":"181722123X","type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedDisp":"July 6, 2011","dateIssuedKey":"2011"}],"person":[{"role":"aut","given":"Brigitte","roleDisplay":"VerfasserIn","family":"Neuber","display":"Neuber, Brigitte"},{"given":"Isabelle","roleDisplay":"VerfasserIn","role":"aut","display":"Krämer, Isabelle","family":"Krämer"},{"roleDisplay":"VerfasserIn","given":"Claudia","role":"aut","family":"Tolliver","display":"Tolliver, Claudia"},{"role":"aut","roleDisplay":"VerfasserIn","given":"Stefan","family":"Schönland","display":"Schönland, Stefan"},{"family":"Hegenbart","display":"Hegenbart, Ute","role":"aut","roleDisplay":"VerfasserIn","given":"Ute"},{"role":"aut","given":"Dirk","roleDisplay":"VerfasserIn","display":"Hose, Dirk","family":"Hose"},{"role":"aut","roleDisplay":"VerfasserIn","given":"Mathias","family":"Witzens-Harig","display":"Witzens-Harig, Mathias"},{"family":"Ho","display":"Ho, Anthony Dick","roleDisplay":"VerfasserIn","given":"Anthony Dick","role":"aut"},{"display":"Goldschmidt, Hartmut","family":"Goldschmidt","roleDisplay":"VerfasserIn","given":"Hartmut","role":"aut"},{"family":"Klein","display":"Klein, Bernard","given":"Bernard","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","given":"Michael","roleDisplay":"VerfasserIn","display":"Hundemer, Michael","family":"Hundemer"}],"title":[{"title_sort":"Lenalidomide enhances antigen-specific activity and decreases CD45RA expression of T cells from patients with multiple myeloma","title":"Lenalidomide enhances antigen-specific activity and decreases CD45RA expression of T cells from patients with multiple myeloma"}],"physDesc":[{"extent":"10 S."}]} | ||
| SRT | |a NEUBERBRIGLENALIDOMI6201 | ||